Chemoinformaics analysis of BETA-CRYPTOXANTHIN-PALMITATE
| Molecular Weight | 791.302 | nRot | 25 |
| Heavy Atom Molecular Weight | 704.614 | nRig | 22 |
| Exact Molecular Weight | 790.663 | nRing | 2 |
| Solubility: LogS | -8.789 | nHRing | 0 |
| Solubility: LogP | 15.137 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 144 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 58 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 86 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 56 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 152.468 |
| nHD | 0 | BPOL | 88.8798 |
| QED | 0.052 |
| Synth | 4.488 |
| Natural Product Likeliness | 1.185 |
| NR-PPAR-gamma | 0.655 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.975 |
| Pgp-sub | 0.398 |
| HIA | 0.063 |
| CACO-2 | -5.737 |
| MDCK | 0.0000031 |
| BBB | 0.001 |
| PPB | 1.0803 |
| VDSS | 9.438 |
| FU | 0.00419239 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.279 |
| CYP2c19-inh | 0.046 |
| CYP2c19-sub | 0.979 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.862 |
| CYP2d6-inh | 0.719 |
| CYP2d6-sub | 0.976 |
| CYP3a4-inh | 0.215 |
| CYP3a4-sub | 0.914 |
| CL | 0.876 |
| T12 | 0.007 |
| hERG | 0.859 |
| Ames | 0.124 |
| ROA | 0.125 |
| SkinSen | 0.993 |
| Carcinogencity | 0.022 |
| EI | 0.02 |
| Respiratory | 0.223 |
| NR-Aromatase | 0.981 |
| Antiviral | Yes |
| Prediction | 0.742221 |